Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
HAMLETT
2024-518769-80-00Phase 4Authorised
- Sponsor
- University Medical Center Groningen
- Start
- Nov 2024
- Modality
- Small Molecules, Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised, single-blind trial of haloperidol, clozapine, tiapride, sertindole, paliperidone and 9 more in Schizophrenia Spectrum Disorders (SSD) and psychosis (2 arms), sponsored by University Medical Center Groningen. Primary endpoint: Long-term social recovery. Planned start Nov 2024; status: authorised.
02
Drugs
haloperidolclozapinetiapridesertindolepaliperidone
03
Conditions
Schizophrenia Spectrum Disorders (SSD)psychosis
Beyond the preview
Go deeper on 2024-518769-80-00.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2024-518769-80-00.